During each transplantation passage of a line of mouse myeloma tumor MOPC-315 through syngeneic (BALB/c) hosts, the tumor cells lose reactivity with cytotoxic thymus-derived lymphocytes directed against products of the
reactivity on transfer to fresh hosts. In contrast to this cyclical change, the tumor cells remain uniformly reactive with anti-H-2d alloantisera throughout the transplantation cycle. The major histocompatibility complex (MHC) is a large cluster of linked genes coding for cell surface proteins that control a number of immune processes, including allograft rejection and interactions among syngeneic lymphoid cells. In a recently discovered effect, products of the MHC restrict the reactions of thymus-derived lymphocytes (T lymphocytes) with diverse surface antigens of syngeneic target cells. For example, in the mouse (in which the MHC is called H-2 and this restriction has been mostly clearly defined), lysis of virus-infected target cells by cytotoxic T lymphocytes (CTLs) has a dual requirement: the most effectively lysed cells are those with both the same virus infection and H-2 products as the stimulator cells that elicited development of the CTLs (1) . By testing stimulator and target cells from various parental and recombinant mouse strains, differing only in restricted regions of the MHC, it has become apparent that the restrictive H-2 products are coded for by the H-2K and/or H-2D loci, located at either end of the H-2 complex (2).
H-2 restriction of CTL activity is also evident with target cells whose surface antigens are modified chemically with 2,4,6-trinitrophenyl or other groups (3) (4) (5) and with normal cells via their many minor histocompatibility antigens (i.e., antigens that elicit weak allograft rejection reactions and are controlled by genes outside the MHC) (6, 7) . It is thus expected that syngeneic CTL responses to tumor-associated antigens on tumor cells are probably also subject to the same dual requirement for antigen plus H-2 products, and this expectation is supported by several observations (8) (9) (10) . Accordingly, tumors that fail to react with syngeneic CTLs could be expected to lack either a tumor-specific antigen as has been described (11) or the appropriate H-2 products.
In accord with these considerations, we describe in this paper a transplantable mouse myeloma tumor of BALB/c origin (H-2d haplotype) that undergoes a periodic loss, during each transplantation cycle, of ability to interact with CTLs directed against products of the H-2d haplotype. Nevertheless, throughout the transplantation cycle the tumor retains undiminished ability to react with alloantibodies to H-2d products.
This discrepancy suggests, in accord with some other observations (12) (13) (14) (15) The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact. Absorption of Antibodies to H-2.d. Serial dilutions of cells that had been washed three times by repeated cycles of centrifugation were distributed into microtest tubes (Sarstedt, Princeton, NJ) and centrifuged (450 X g, 5 min); the supernatants were removed, and the packed cells were resuspended in 60 ,ul of antiserum to H-2d at dilutions that would lyse approximately 75% of the target cells in a standard cytotoxic assay with complement (see below). After 30 min on ice, during which the tubes were periodically agitated by gentle vortex mixing, the cells were packed by centrifugation (8000 X g, S minm Brinkman centrifuge, model 3200) and samples of the supernatant were diluted and distributed into microtiter plates (Linbro Scientific) for storage at -700 until assayed for cytotoxic antibodies (below). Cell Lysis by Anti-H-2d Antibodies Plus Complement. To 25-Al dilutions of unadsorbed or adsorbed sera in microtiter plates (above) was added 25 ,d containing 5 X 104 5ICr-labeled Con A blasts of spleen cells from mice of the appropriate strains. After incubation for 30 min at room temperature, the plates were centrifuged (450 X g, 5 min), the supernatants were discarded, and the cells were washed once. Complement was then added (50 Al) as a 1:4 dilution of normal rabbit serum (previously selected for minimal cytotoxicity and also adsorbed with a mixture of mouse tumor and normal cells). After 1 hr at 370, the cells were washed once and their radioactivity (51Cr) was determined. In one experiment, cytotoxicity was evaluated by trypan blue exclusion rather than by 51Cr release (see Table   1 ). Fig. 1A , MOPC-315 cells harvested 9 days after transfer were less sensitive to lysis than those harvested 5 days after transfer; at neither time were they as susceptible as MOPC-167 cells.
The difference in sensitivity of "early" and "late" MOPC-315 cells was verified with cells harvested 4, 7, and 11 days after transfer (Fig. 1B) . The same cells were also tested for their ability to inhibit the lysis of standard H-2d target cells (Con A blasts of BALB/c spleen) by alloreactive anti-H-2d CTLs. As shown in Fig. 2 , the progressively decreasing susceptibility to lysis during the transplantation cycle was matched by a corresponding decrease in ability to inhibit the anti-H-2d CTLs. Inhibition of lysis at inhibitor:target ratios > 100:1 is probably not significant because nonspecific controls (EL-4) were also somewhat inhibitory at this level. The cyclical change in reactivity with CTLs was evident when cells taken at 11 days were inoculated into fresh recipients: cells collected 4 days later had regained reactivity with CTLs.
In addition to the failure of the late MOPC-315 cells to interact with anti-H-2d CTLs, either as targets or as inhibitors, these cells were also less effective than the early tumor cells as stimulators of the development of anti-H-2d CTLs in BALB.B (H-2b) spleen cells (Fig. 3A) . A mixing experiment (Fig. 3B) demonstrated that late cells did not interfere with the response to MOPC-167. Thus, the failure of the late cells to stimulate a response is related to antigen recognition rather than to inhibition of proliferation and maturation of the CTLs.
To determine whether the presence of the serologically defined cell surface antigens coded for by the H-2 complex were also intermittently diminished, tumor cells were tested both for their susceptibility to lysis by anti-H-2d alloantibodies and for their ability to bind these antibodies. In contrast to the progressive loss of reactivity with CTLs, MOPC-315 cells collected 4, 7, and 11 days after transfer were identical as targets for the anti-H-2d antisera (Fig. 4) and as adsorbents of cytotoxic antibodies from these sera (Fig. 5) BALB.HTG (db) and B1O.A(5R) (bd) cells were targets for measuring antibodies to products of the H-2Kd and Dd alleles, respectively (Fig. 5) .
All the MOPC-315 cells tested as targets, inhibitors, and stimulators were derived from ascites fluid, and it seemed possible that changing levels of contamination by host cells might account for the systematic changes with time in reactivity with anti-H-2 CTLs. To test this possibility, MOPC-315 cells were grown in F1 hosts (H-2d X H-2b), and tumor cell populations harvested at various times were tested with anti-H-2d and anti-H-2b CTLs and the corresponding antisera for the presence of host cells. With anti-H-2d CTLs, only the early tumor cells were significantly lysed, in agreement with results already shown (Figs. land 6A) ; with the anti-H-2b CTLs, both early and late populations were lysed minimally, if at all (Fig.  6B) . As is shown in Table 1 with anti-H-2d alloantibodies, less than 10% of the ascites cells derived from the F1 mice were host cells, regardless of the time at which tumor cells were collected. DISCUSSION The main finding in this study is that, late in each transplantation cycle, cells of MOPC-315, a BALB/c myeloma tumor, undergo a periodic loss in ability to elicit or react with anti-H-2d CTLs. Nevertheless, throughout the entire cycle the tumor cells retain undiminished their ability to react with anti-H-2d alloantibodies. These findings are in accord with studies of mutant H_2Kb alleles, which suggest that anti-H-2 CTLs and anti-H-2 alloantibodies react with different determinants on the cell surface molecules encoded by the H-2K and H-2D loci (14, 15 
